Analyst consensus rating
Boundless Bio Analyst Rating: none
Direct answer
Boundless Bio's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked October 18, 2026.
Get free Boundless Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.34
- Average price target
- $4.00
- High price target
- $4.00
- Low price target
- $4.00
- Low target gap
- +70.9%
- Target upside
- +70.9%
- High target gap
- +70.9%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Boundless Bio?
Boundless Bio has a verified none consensus. The same dataset has an average price target of $4.00.
How far are Boundless Bio's low and high targets from the recorded price?
The low target implies +70.9%, while the high target implies +70.9%.
How many analysts are included in Boundless Bio's consensus?
The verified consensus includes 1 analysts.
How is Boundless Bio's target upside or downside calculated?
The average target of $4.00 is divided by the recorded price of $2.34, then one is subtracted to produce +70.9%. This does not guarantee a future return.
When was Boundless Bio's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.